View in EDS

Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss.

Saved in:
Bibliographic Details
Title: Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss.
Authors: Fedoriw A; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., Rajapurkar SR; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., O'Brien S; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., Gerhart SV; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., Mitchell LH; Epizyme, Inc, Cambridge, MA 02139, USA., Adams ND; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., Rioux N; Epizyme, Inc, Cambridge, MA 02139, USA., Lingaraj T; Epizyme, Inc, Cambridge, MA 02139, USA., Ribich SA; Epizyme, Inc, Cambridge, MA 02139, USA., Pappalardi MB; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., Shah N; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., Laraio J; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., Liu Y; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., Butticello M; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., Carpenter CL; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., Creasy C; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., Korenchuk S; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., McCabe MT; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., McHugh CF; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., Nagarajan R; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, PA 19426, USA., Wagner C; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, PA 19426, USA., Zappacosta F; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, PA 19426, USA., Annan R; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, PA 19426, USA., Concha NO; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, PA 19426, USA., Thomas RA; Nonclinical Safety Assessment, GlaxoSmithKline, Collegeville, PA 19426, USA., Hart TK; Nonclinical Safety Assessment, GlaxoSmithKline, Collegeville, PA 19426, USA., Smith JJ; Epizyme, Inc, Cambridge, MA 02139, USA., Copeland RA; Epizyme, Inc, Cambridge, MA 02139, USA., Moyer MP; Epizyme, Inc, Cambridge, MA 02139, USA., Campbell J; Epizyme, Inc, Cambridge, MA 02139, USA., Stickland K; Epizyme, Inc, Cambridge, MA 02139, USA., Mills J; Epizyme, Inc, Cambridge, MA 02139, USA., Jacques-O'Hagan S; Epizyme, Inc, Cambridge, MA 02139, USA., Allain C; Epizyme, Inc, Cambridge, MA 02139, USA., Johnston D; Epizyme, Inc, Cambridge, MA 02139, USA., Raimondi A; Epizyme, Inc, Cambridge, MA 02139, USA., Porter Scott M; Epizyme, Inc, Cambridge, MA 02139, USA., Waters N; Epizyme, Inc, Cambridge, MA 02139, USA., Swinger K; Epizyme, Inc, Cambridge, MA 02139, USA., Boriack-Sjodin A; Epizyme, Inc, Cambridge, MA 02139, USA., Riera T; Epizyme, Inc, Cambridge, MA 02139, USA., Shapiro G; Epizyme, Inc, Cambridge, MA 02139, USA., Chesworth R; Epizyme, Inc, Cambridge, MA 02139, USA., Prinjha RK; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., Kruger RG; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., Barbash O; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA., Mohammad HP; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA. Electronic address: helai.x.mohammad@gsk.com.
Source: Cancer cell [Cancer Cell] 2019 Jul 08; Vol. 36 (1), pp. 100-114.e25. Date of Electronic Publication: 2019 Jun 27.
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31257072
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fedoriw+A%22">Fedoriw A</searchLink>; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Rajapurkar+SR%22">Rajapurkar SR</searchLink>; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22O'Brien+S%22">O'Brien S</searchLink>; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Gerhart+SV%22">Gerhart SV</searchLink>; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Mitchell+LH%22">Mitchell LH</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Adams+ND%22">Adams ND</searchLink>; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Rioux+N%22">Rioux N</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Lingaraj+T%22">Lingaraj T</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Ribich+SA%22">Ribich SA</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Pappalardi+MB%22">Pappalardi MB</searchLink>; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Shah+N%22">Shah N</searchLink>; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Laraio+J%22">Laraio J</searchLink>; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Butticello+M%22">Butticello M</searchLink>; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Carpenter+CL%22">Carpenter CL</searchLink>; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Creasy+C%22">Creasy C</searchLink>; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Korenchuk+S%22">Korenchuk S</searchLink>; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22McCabe+MT%22">McCabe MT</searchLink>; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22McHugh+CF%22">McHugh CF</searchLink>; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Nagarajan+R%22">Nagarajan R</searchLink>; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Wagner+C%22">Wagner C</searchLink>; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Zappacosta+F%22">Zappacosta F</searchLink>; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Annan+R%22">Annan R</searchLink>; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Concha+NO%22">Concha NO</searchLink>; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+RA%22">Thomas RA</searchLink>; Nonclinical Safety Assessment, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Hart+TK%22">Hart TK</searchLink>; Nonclinical Safety Assessment, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Smith+JJ%22">Smith JJ</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Copeland+RA%22">Copeland RA</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Moyer+MP%22">Moyer MP</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Campbell+J%22">Campbell J</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Stickland+K%22">Stickland K</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Mills+J%22">Mills J</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Jacques-O'Hagan+S%22">Jacques-O'Hagan S</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Allain+C%22">Allain C</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Johnston+D%22">Johnston D</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Raimondi+A%22">Raimondi A</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Porter+Scott+M%22">Porter Scott M</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Waters+N%22">Waters N</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Swinger+K%22">Swinger K</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Boriack-Sjodin+A%22">Boriack-Sjodin A</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Riera+T%22">Riera T</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Shapiro+G%22">Shapiro G</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Chesworth+R%22">Chesworth R</searchLink>; Epizyme, Inc, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Prinjha+RK%22">Prinjha RK</searchLink>; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Kruger+RG%22">Kruger RG</searchLink>; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Barbash+O%22">Barbash O</searchLink>; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Mohammad+HP%22">Mohammad HP</searchLink>; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA 19426, USA. Electronic address: helai.x.mohammad@gsk.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101130617%22">Cancer cell</searchLink> [Cancer Cell] 2019 Jul 08; Vol. 36 (1), pp. 100-114.e25. <i>Date of Electronic Publication: </i>2019 Jun 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101130617 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-3686 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215356108%22">15356108 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Cell <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31257072
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ccell.2019.05.014
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100
    Titles:
      – TitleFull: Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fedoriw A
      – PersonEntity:
          Name:
            NameFull: Rajapurkar SR
      – PersonEntity:
          Name:
            NameFull: O'Brien S
      – PersonEntity:
          Name:
            NameFull: Gerhart SV
      – PersonEntity:
          Name:
            NameFull: Mitchell LH
      – PersonEntity:
          Name:
            NameFull: Adams ND
      – PersonEntity:
          Name:
            NameFull: Rioux N
      – PersonEntity:
          Name:
            NameFull: Lingaraj T
      – PersonEntity:
          Name:
            NameFull: Ribich SA
      – PersonEntity:
          Name:
            NameFull: Pappalardi MB
      – PersonEntity:
          Name:
            NameFull: Shah N
      – PersonEntity:
          Name:
            NameFull: Laraio J
      – PersonEntity:
          Name:
            NameFull: Liu Y
      – PersonEntity:
          Name:
            NameFull: Butticello M
      – PersonEntity:
          Name:
            NameFull: Carpenter CL
      – PersonEntity:
          Name:
            NameFull: Creasy C
      – PersonEntity:
          Name:
            NameFull: Korenchuk S
      – PersonEntity:
          Name:
            NameFull: McCabe MT
      – PersonEntity:
          Name:
            NameFull: McHugh CF
      – PersonEntity:
          Name:
            NameFull: Nagarajan R
      – PersonEntity:
          Name:
            NameFull: Wagner C
      – PersonEntity:
          Name:
            NameFull: Zappacosta F
      – PersonEntity:
          Name:
            NameFull: Annan R
      – PersonEntity:
          Name:
            NameFull: Concha NO
      – PersonEntity:
          Name:
            NameFull: Thomas RA
      – PersonEntity:
          Name:
            NameFull: Hart TK
      – PersonEntity:
          Name:
            NameFull: Smith JJ
      – PersonEntity:
          Name:
            NameFull: Copeland RA
      – PersonEntity:
          Name:
            NameFull: Moyer MP
      – PersonEntity:
          Name:
            NameFull: Campbell J
      – PersonEntity:
          Name:
            NameFull: Stickland K
      – PersonEntity:
          Name:
            NameFull: Mills J
      – PersonEntity:
          Name:
            NameFull: Jacques-O'Hagan S
      – PersonEntity:
          Name:
            NameFull: Allain C
      – PersonEntity:
          Name:
            NameFull: Johnston D
      – PersonEntity:
          Name:
            NameFull: Raimondi A
      – PersonEntity:
          Name:
            NameFull: Porter Scott M
      – PersonEntity:
          Name:
            NameFull: Waters N
      – PersonEntity:
          Name:
            NameFull: Swinger K
      – PersonEntity:
          Name:
            NameFull: Boriack-Sjodin A
      – PersonEntity:
          Name:
            NameFull: Riera T
      – PersonEntity:
          Name:
            NameFull: Shapiro G
      – PersonEntity:
          Name:
            NameFull: Chesworth R
      – PersonEntity:
          Name:
            NameFull: Prinjha RK
      – PersonEntity:
          Name:
            NameFull: Kruger RG
      – PersonEntity:
          Name:
            NameFull: Barbash O
      – PersonEntity:
          Name:
            NameFull: Mohammad HP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 07
              Text: 2019 Jul 08
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1878-3686
          Numbering:
            – Type: volume
              Value: 36
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cancer cell
              Type: main
ResultId 1